ArticleMolecular therapy oncolytics2021

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2.

Wei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.